Research ArticleArticle
Miscarriage and Stillbirth in Women with Rheumatoid Arthritis
Marianne Wallenius, Kjell Å. Salvesen, Anne K. Daltveit and Johan F. Skomsvoll
The Journal of Rheumatology July 2015, jrheum.141553; DOI: https://doi.org/10.3899/jrheum.141553
Marianne Wallenius
From the National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, and the National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital; Department of Neuroscience, and Department of Laboratory Medicine, Women’s and Child Health, Norwegian University of Science and Technology (NTNU), Trondheim; Department of Global Public Health and Primary Care, University of Bergen; Medical Birth Registry of Norway (MBRN), Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway. Supported by the Liaison Committee between the Central Norway Regional Health Authority and the NTNU. M. Wallenius, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, and the Department of Neuroscience, NTNU; K.Å. Salvesen, MD, PhD, National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital, and the Department of Laboratory Medicine, Women’s and Child Health, NTNU; A.K. Daltveit, PhD, Department of Global Public Health and Primary Care, University of Bergen, and the MBRN, Division of Epidemiology, Norwegian Institute of Public Health; J.F. Skomsvoll, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital. Address correspondence to Dr. M. Wallenius, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olav’s Hospital (Trondheim University Hospital), Bevegelsessenteret, N-7006 Trondheim, Norway. E-mail: marianne.wallenius@ntnu.no. Accepted for publication May 26, 2015.
Kjell Å. Salvesen
From the National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, and the National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital; Department of Neuroscience, and Department of Laboratory Medicine, Women’s and Child Health, Norwegian University of Science and Technology (NTNU), Trondheim; Department of Global Public Health and Primary Care, University of Bergen; Medical Birth Registry of Norway (MBRN), Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway. Supported by the Liaison Committee between the Central Norway Regional Health Authority and the NTNU. M. Wallenius, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, and the Department of Neuroscience, NTNU; K.Å. Salvesen, MD, PhD, National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital, and the Department of Laboratory Medicine, Women’s and Child Health, NTNU; A.K. Daltveit, PhD, Department of Global Public Health and Primary Care, University of Bergen, and the MBRN, Division of Epidemiology, Norwegian Institute of Public Health; J.F. Skomsvoll, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital. Address correspondence to Dr. M. Wallenius, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olav’s Hospital (Trondheim University Hospital), Bevegelsessenteret, N-7006 Trondheim, Norway. E-mail: marianne.wallenius@ntnu.no. Accepted for publication May 26, 2015.
Anne K. Daltveit
From the National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, and the National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital; Department of Neuroscience, and Department of Laboratory Medicine, Women’s and Child Health, Norwegian University of Science and Technology (NTNU), Trondheim; Department of Global Public Health and Primary Care, University of Bergen; Medical Birth Registry of Norway (MBRN), Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway. Supported by the Liaison Committee between the Central Norway Regional Health Authority and the NTNU. M. Wallenius, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, and the Department of Neuroscience, NTNU; K.Å. Salvesen, MD, PhD, National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital, and the Department of Laboratory Medicine, Women’s and Child Health, NTNU; A.K. Daltveit, PhD, Department of Global Public Health and Primary Care, University of Bergen, and the MBRN, Division of Epidemiology, Norwegian Institute of Public Health; J.F. Skomsvoll, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital. Address correspondence to Dr. M. Wallenius, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olav’s Hospital (Trondheim University Hospital), Bevegelsessenteret, N-7006 Trondheim, Norway. E-mail: marianne.wallenius@ntnu.no. Accepted for publication May 26, 2015.
Johan F. Skomsvoll
From the National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, and the National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital; Department of Neuroscience, and Department of Laboratory Medicine, Women’s and Child Health, Norwegian University of Science and Technology (NTNU), Trondheim; Department of Global Public Health and Primary Care, University of Bergen; Medical Birth Registry of Norway (MBRN), Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway. Supported by the Liaison Committee between the Central Norway Regional Health Authority and the NTNU. M. Wallenius, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital, and the Department of Neuroscience, NTNU; K.Å. Salvesen, MD, PhD, National Center for Fetal Medicine, Department of Obstetrics and Gynecology, Trondheim University Hospital, and the Department of Laboratory Medicine, Women’s and Child Health, NTNU; A.K. Daltveit, PhD, Department of Global Public Health and Primary Care, University of Bergen, and the MBRN, Division of Epidemiology, Norwegian Institute of Public Health; J.F. Skomsvoll, MD, PhD, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, Trondheim University Hospital. Address correspondence to Dr. M. Wallenius, National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olav’s Hospital (Trondheim University Hospital), Bevegelsessenteret, N-7006 Trondheim, Norway. E-mail: marianne.wallenius@ntnu.no. Accepted for publication May 26, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Miscarriage and Stillbirth in Women with Rheumatoid Arthritis
Marianne Wallenius, Kjell Å. Salvesen, Anne K. Daltveit, Johan F. Skomsvoll
The Journal of Rheumatology Jul 2015, jrheum.141553; DOI: 10.3899/jrheum.141553